SEC Form 4 · accession 0001209191-18-056201
NEXTGEN HEALTHCARE, INC. · NXGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John R Frantz
Officer — CEO and President · Director
Period of report
Oct 23, 2018
Accepted (ET)
Oct 25, 2018 · 5:22 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000708818
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| COMMON STOCKF1 | Oct 23, 2018 | A | 190,000 | $0.00 | A | 299,264 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Performance stock unitsF2 | — | Oct 23, 2018 | A | 101,600 | A | — | — | Common stock | 101,600 | 101,600 | D |
Explanation of responses
- F1These shares of restricted stock vest over four years from the date of grant in semi-annual increments as follows: 15% vest at 6 months; 15% vest at 12 months; 15% vest at 18 months; 15% vest at 24 months; 15% vest at 30 months, 15% vest at 36 months; 5% vest at 42 months; and 5% vest at 48 months.
- F2Represent performance stock unit awards vesting in the event certain performance goals are achieved and there is continuous service through the date the goals are certified. Approximately 34% of the performance stock units are tied to the Issuer's cumulative 3-year TSR goals, 33% are tied to the issuer's fiscal year 2021 revenues and 33% are tied to the issuer fiscal year 2021 adjusted EPS goals.The number of shares to be issued may vary between fifty percent and two hundred percent of the number of performance stock units depending on performance, and no such shares will be issued if threshold performance is not achieved. The number of shares shown in the table assumes the attainment of the goals at target or one hundred percent.